Invention Grant
- Patent Title: Crystalline isoxazole hydroxamic acid compounds
-
Application No.: US15620373Application Date: 2017-06-12
-
Publication No.: US10071973B2Publication Date: 2018-09-11
- Inventor: Jiping Fu , Siyi Jiang , Andreas Kordikowski , Zachary Kevin Sweeney
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Mark H. Hopkins
- Priority: WOPCT/CN2016/085694 20160614
- Main IPC: C07D261/08
- IPC: C07D261/08 ; A61K31/7048 ; A61K38/14 ; A61K38/12 ; A61K31/431 ; A61K31/65 ; A61K31/7036 ; A61K31/496 ; A61K31/5383 ; A61K31/42 ; A61K31/43 ; A61K31/546

Abstract:
This invention pertains to a crystalline compound of Formula (A) as described herein and compositions containing this crystalline compound, as well as methods of using the compound or pharmaceutical compositions comprising it to treat bacterial infections. The compound and compositions are especially useful to treat Gram negative bacterial infections, including multi-drug resistant strains.
Public/Granted literature
- US20170355684A1 CRYSTALLINE ISOXAZOLE HYDROXAMIC ACID COMPOUNDS Public/Granted day:2017-12-14
Information query